Zanubrutinib for the treatment of chronic lymphocytic leukemia

被引：0
|
作者：
Bruzzese, Antonella [1 ]
Martino, Enrica Antonia [1 ]
Labanca, Caterina [1 ]
Mendicino, Francesco [1 ]
Lucia, Eugenio [1 ]
Olivito, Virginia [1 ]
Neri, Antonino [2 ]
Morabito, Fortunato [3 ]
Vigna, Ernesto [1 ]
Gentile, Massimo [1 ,4 ,5 ]
机构：
[1] Azienda Osped Annunziata, Hematol Unit, Cosenza, Italy
[2] Sci Directorate IRCCS Reggio Emilia, Reggio Emilia, Italy
[3] AO Cosenza, Biotechnol Res Unit, Cosenza, Italy
[4] Univ Calabria, Dept Pharm Hlth & Nutr Sci, Arcavacata Di Rende, Italy
[5] Azienda Osped Annunziata, Hematol Unit, I-87100 Cosenza, Italy
来源：
EXPERT OPINION ON PHARMACOTHERAPY | 2023年 / 24卷 / 13期
关键词：
Zanubrutinb; CLL; therapy; BTKi; precision medicine; IBRUTINIB; OBINUTUZUMAB; VENETOCLAX; DISCONTINUATION;
D O I：
10.1080/14656566.2023.2229734
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1409 / 1413
页数：5
相关论文
共 50 条
  • [21] ZANUBRUTINIB INDUCED COMPLETE HEART BLOCK IN A PATIENT WITH CHRONIC LYMPHOCYTIC LEUKEMIA
    Alawadhi, Yusuf
    Secrest, Kayla M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2025, 85 (12) : 3992 - 3992
  • [22] Zanubrutinib monotherapy for patients with treatment-naive chronic lymphocytic leukemia and 17p deletion
    Tam, Constantine S.
    Robak, Tadeusz
    Ghia, Paolo
    Kahl, Brad S.
    Walker, Patricia
    Janowski, Wojciech
    Simpson, David
    Shadman, Mazyar
    Ganly, Peter S.
    Laurenti, Luca
    Opat, Stephen
    Tani, Monica
    Ciepluch, Hanna
    Verner, Emma
    Simkovi, Martin
    Osterborg, Anders
    Trneny, Marek
    Tedeschi, Alessandra
    Paik, Jason C.
    Kuwahara, Sowmya B.
    Feng, Shibao
    Ramakrishnan, Vanitha
    Cohen, Aileen
    Huang, Jane
    Hillmen, Peter
    Brown, Jennifer R.
    HAEMATOLOGICA, 2021, 106 (09) : 2354 - 2363
  • [23] ALPINE: zanubrutinib versus ibrutinib in relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma
    Hillmen, Peter
    Brown, Jennifer R.
    Eichhorst, Barbara F.
    Lamanna, Nicole
    O'Brien, Susan M.
    Qiu, Lugui
    Salmi, Tommi
    Hilger, James
    Wu, Kenneth
    Cohen, Aileen
    Huang, Jane
    Tam, Constantine S.
    FUTURE ONCOLOGY, 2020, 16 (10) : 517 - 523
  • [24] BUDGET IMPACT ANALYSIS OF ZANUBRUTINIB FOR PATIENTS WITH TREATMENT-NAIVE CHRONIC LYMPHOCYTIC LEUKEMIA OR SMALL LYMPHOCYTIC LYMPHOMA IN THE UNITED STATES
    Liu, S.
    Yang, K.
    Xiao, Y.
    Gani, R.
    Xue, M.
    Tang, B.
    VALUE IN HEALTH, 2022, 25 (12) : S120 - S120
  • [25] Safety and efficacy of zanubrutinib in the management of chronic lymphocytic leukemia/small lymphocytic leukemia: a systematic review and meta-analysis
    Abdur Jamil
    Zaheer Qureshi
    Rimsha Siddique
    Faryal Altaf
    Asim Kichloo
    Discover Medicine, 2 (1):
  • [26] Plain language summary of zanubrutinib or ibrutinib in chronic lymphocytic leukemia that is resistant to treatment or has come back after treatment
    Brown, Jennifer R.
    Eichhorst, Barbara
    Hillmen, Peter
    Jurczak, Wojciech
    Kazmierczak, Maciej
    Lamanna, Nicole
    O'Brien, Susan M.
    Tam, Constantine S.
    Qiu, Lugui
    Zhou, Keshu
    Simkovic, Martin
    Mayer, Jiri
    Gillespie-Twardy, Amanda
    Ferrajoli, Alessandra
    Ganly, Peter S.
    Weinkove, Robert
    Grosicki, Sebastian
    Mital, Andrzej
    Robak, Tadeusz
    Osterborg, Anders
    Yimer, Habte A.
    Salmi, Tommi
    Wang, Megan-Der-Yu
    Fu, Lina
    Li, Jessica
    Wu, Kenneth
    Cohen, Aileen
    Shadman, Mazyar
    FUTURE ONCOLOGY, 2024, 20 (12) : 717 - 726
  • [27] Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Kang, Dong-Won
    Wang, Li
    Short, Nicholas J.
    Ferrajoli, Alessandra
    Wang, Yucai
    Zhou, Shouhao
    Shen, Chan
    PHARMACOECONOMICS, 2024, 42 (04) : 409 - 418
  • [28] Cost Effectiveness of Zanubrutinib Versus Ibrutinib in Relapsed or Refractory Chronic Lymphocytic Leukemia
    Dong-Won Kang
    Li Wang
    Nicholas J. Short
    Alessandra Ferrajoli
    Yucai Wang
    Shouhao Zhou
    Chan Shen
    PharmacoEconomics, 2024, 42 : 409 - 418
  • [29] Zanubrutinib more effective and better tolerated than ibrutinib for chronic lymphocytic leukemia and small lymphocytic lymphoma
    Nierengarten, Mary Beth
    CANCER, 2023, 129 (10) : 1466 - 1466
  • [30] Treatment of chronic lymphocytic leukemia
    Ferrajoli, A
    O'Brien, SM
    SEMINARS IN ONCOLOGY, 2004, 31 (02) : 60 - 65
12345